Hepatology research includes a wide array of diseases affecting liver function that can stem from diverse etiologies including autoimmune conditions, malnutrition, cancer, and infectious disease complications. CTI’s therapeutic expertise specific to liver diseases is one of the driving forces behind our ability to successfully design and manage drug development programs in this area. We specialize in the unique challenges associated with hepatic populations, from mild to moderate liver disease to end stage acute and chronic liver disease. 

Our Medical Directors, including a former transplant surgeon, work closely with the rest of our organization so that project teams are familiar with hepatic diseases and associated complications. We attend industry meetings and are members of many hepatology related societies, including the American Association of Liver Disease (AASLD), the European Association for the Study of the Liver (EASL), the International Liver Transplantation Society (ILTS), and Studies in Pediatric Liver Transplantation (SPLIT).